EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma

Xueying Li, Desi Chen, Yepeng Guo, Gaowei Huang, Zijian Cai, Ting Xue, Zhaohui Chen, Hui Han, Zaishang Li

Cancer Immunology, Immunotherapy · 17.03.2026 · 75 (4)

DOI: 10.1007/s00262-026-04348-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 17.03.2026. Verfasst von Xueying Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Chemokine CCL21, Carcinoma, Squamous Cell, B-Lymphocytes, Penile Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Shenzhen Science and Technology Innovation Commission Outstanding Youth Basic Research Project, Shenzhen People's Hospital Clinical Scientist Cultivation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Penile squamous cell carcinoma (PSCC) is an aggressive malignancy with a poor prognosis and limited therapeutic options. Tertiary lymphoid structures (TLSs) can support antitumour immunity, yet TLS maturation and maturation-associated stromal determinants in PSCC remain unclear. Here, we integrated hematoxylin and eosin (H&E) staining, multiplex immunohistochemical (mIHC) colocalization, spatial transcriptomics, single-cell RNA sequencing (scRNA-seq), and bulk RNA sequencing (bulk RNA-seq) to profile TLS maturity and TLS-associated stromal-immune features in PSCC. TLS maturity was quantified using an AUCell germinal centre-like signature, and the presence of mature TLSs (mTLSs) coincided with improved survival. We identified a CCL21+ CAF subset that was preferentially enriched in mTLSs, spatially concentrated in the mTLS-core and adjacent to B-cell-rich areas; mIHC further confirmed dense CCL21+ACTA2+ CAFs near CD20+ aggregates. Along an inferred iTLS-to-mTLS continuum, the abundance of CCL21+ CAFs increased, and the expression of chemokines increased. Spatial and transcriptomic analyses further linked B-cell chemotaxis- and activation-related signatures to the CCL21-CCR7 axis, accompanied by germinal centre-like B-cell features. Clinically, higher CCL21 expression, elevated CCL21+ CAF signature scores, and stronger CCL21-CCR7 signatures in B cells were associated with favourable outcomes. Together, these data suggest that CCL21+ CAFs or CCL21 are potential prognostic biomarkers for risk stratification and immune microenvironment profiling and highlight the CCL21-CCR7 axis as a candidate pathway for therapeutic modulation of TLS maturity in PSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CCL21Carcinoma, Squamous CellB-LymphocytesPenile NeoplasmsCancer-Associated FibroblastsTertiary Lymphoid StructuresHumansMaleTumor Microenvironment

Stichwörter der Autor:innen

B-cell recruitmentCCL21+ cancer-associated fibroblastsCCL21–CCR7 axisPenile squamous cell carcinomaTertiary lymphoid structures

Substanzen

Chemokine CCL21CCL21 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, Guangdong, People's Republic of China.
  • Department of Urology, Shenzhen People's Hospital, The Second Clinic Medical College of Jinan University, Shenzhen, 518107, Guangdong, People's Republic of China.
  • Department of Urology, First Affiliated Hospital of Southern, University of Science and Technology, Shenzhen, 518107, Guangdong, People's Republic of China.
  • Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital, Shenzhen, 518107, People's Republic of China.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
  • Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Science and Technology Innovation Commission Outstanding Youth Basic Research Project
  • Shenzhen People's Hospital Clinical Scientist Cultivation Project

Zitieren

APA

Li, X., Chen, D., Guo, Y., Huang, G., Cai, Z., Xue, T., Chen, Z., Han, H., & Li, Z. (2026). Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma. Cancer Immunology, Immunotherapy, 75(4). https://doi.org/10.1007/s00262-026-04348-5

Vancouver

Li X, Chen D, Guo Y, Huang G, Cai Z, Xue T, et al. Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma. Cancer Immunology, Immunotherapy. 2026;75(4). doi:10.1007/s00262-026-04348-5

BibTeX
@article{Li2026,
  author = {Li, Xueying and Chen, Desi and Guo, Yepeng and Huang, Gaowei and Cai, Zijian and Xue, Ting and Chen, Zhaohui and Han, Hui and Li, Zaishang},
  title = {Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  volume = {75},
  number = {4},
  doi = {10.1007/s00262-026-04348-5}
}
Kostenlos starten →